AirSculpt Technologies, Inc. (AIRS) vs Anavex Life Sciences Corp. (AVXL)
A side-by-side comparison of AirSculpt Technologies, Inc. and Anavex Life Sciences Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.92HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
AVXL
Anavex Life Sciences Corp.
$1.61HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — AIRS vs AVXL
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)AVXL -90.8% (-37.9%/yr)AIRS compounded faster over this window
AIRS AVXL
AIRS vs AVXL: by the numbers
- •AVXL is the larger company ($149M vs $135M market cap).
- •Both run net losses; AVXL's is the smaller (0.00% vs -7.79% net margin).
Metrics side by side
Valuation
| Metric | AIRS | AVXL |
|---|---|---|
| P/S ratio | 0.90 | N/A |
| P/B ratio | 1.29 | 1.33 |
| EV / EBITDA | 440.22 | N/A |
| FCF yield | 0.56% | N/A |
Profitability
| Metric | AIRS | AVXL |
|---|---|---|
| Gross margin | 57.63% | 0.00% |
| Operating margin | -7.85% | 0.00% |
| Net margin | -7.79% | 0.00% |
| ROE | -11.20% | -21.38% |
| ROIC | -7.01% | -27.25% |
Growth (annualized)
| Metric | AIRS | AVXL |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | N/A |
| FCF CAGR (5Y) | -52.36% | N/A |
| Total return CAGR (5Y) | N/A | -37.74% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.